Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/125354
Title: Aerosol therapy during non-invasive mechanical ventilation: Review of key technical factors and clinical implications
Authors: Esquinas, A.M.
BaHammam, A.
Scala, R.
Arie, S.
Nasilowski, J.
Siekmeier, R.
Koksal, G.M.
Celikel, T.
Shah, P.S.
Mukhopadhyay, A. 
Cosentini, R.
Papadakos, P.J.
Keywords: Aerosol therapy
Bi-level positive airway pressure
Chronic obstructive pulmonary disease
Continuous positive airway pressure
Metered-dose inhaler
Nebulizers
Non-invasive mechanical ventilation
Issue Date: 2013
Citation: Esquinas, A.M.,BaHammam, A.,Scala, R.,Arie, S.,Nasilowski, J.,Siekmeier, R.,Koksal, G.M.,Celikel, T.,Shah, P.S.,Mukhopadhyay, A.,Cosentini, R.,Papadakos, P.J. (2013). Aerosol therapy during non-invasive mechanical ventilation: Review of key technical factors and clinical implications. Canadian Journal of Respiratory Therapy 49 (1) : 11-18. ScholarBank@NUS Repository.
Abstract: Whereas the evidence supporting aerosol delivery during invasive mechanical ventilation (IMV) is well described, this is not the case for non-invasive mechanical ventilation (NIV) in the treatment of chronic obstructive pulmonary disease or asthma. Several issues that seem to significantly influence aerosol delivery during NIV are still not resolved, such as patient characteristics, the characteristics of the ventilator, ventilatory mode (continuous positive airway pressure vs. bi-level NIV), the use of metered-dose inhalers vs. nebulization, and the interface (nasal vs. facial mask). The aim of this paper is to review the current knowledge of technical factors related to the delivery of aerosol therapy during NIV. In this technical review and analysis, we found that, owing to the still-limited data obtained in clinical practice, aerosol therapy supported by NIV may be considered an added value for improving bronchial obstruction. Despite a strong rationale for the use of NIV to deliver bronchodilators in severe acute obstructive airways diseases, the clinical evidence supporting the largescale application of this practice remains limited. Further investigation is required to achieve a strong level of evidence to support the routine implementation of this therapy.
Source Title: Canadian Journal of Respiratory Therapy
URI: http://scholarbank.nus.edu.sg/handle/10635/125354
ISSN: 12059838
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Page view(s)

22
checked on Oct 26, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.